Derivatives and Hedging Activities - Narrative (Details) - USD ($)		3 Months Ended			6 Months Ended
	Dec. 17, 2021	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2022	Jun. 30, 2021	Oct. 13, 2020
Derivative [Line Items]
Gain (loss) on derivative		$ 0			$ 0
Redeemable securities issued in acquisition					49,965,000	$ 0
Gain on embedded derivative			$ 2,300,000
CIM Portfolio Acquisition
Derivative [Line Items]
Percentage of outstanding common stock available for issuance to determine price	7.50%
Consecutive trading days needed to measure the per share volume weighted average price of common stock for price collar	10 days
Embedded derivative asset				$ 1,700,000
Embedded derivative liability				2,300,000
CIM Portfolio Acquisition | Class A
Derivative [Line Items]
Sale of stock, consideration received on transaction (up to)			$ 53,400,000		$ 53,400,000
Sale of stock, number of shares issued in transaction (in shares)			6,450,107
Consecutive trading days needed to measure the per share volume weighted average price of common stock	5 days
Sale of stock, price per share (in usd per share)	$ 8.34
Gross mortgage notes payable
Derivative [Line Items]
Effective interest rate		3.82%			3.82%
Gross mortgage notes payable | CIM Portfolio Acquisition
Derivative [Line Items]
Redeemable securities issued in acquisition			$ 50,000,000		$ 50,000,000
Sanofi US I | Sanofi US I - New Loan | Gross mortgage notes payable
Derivative [Line Items]
Effective interest rate							3.27%
Interest Rate Swap
Derivative [Line Items]
Notional amount							$ 125,000,000
Interest Rate Swap | Cash Flow Hedging | Derivatives designated as hedging instruments:
Derivative [Line Items]
Proceeds from hedge, financing activities				2,100,000
Interest Rate Swap | Cash Flow Hedging | Derivatives designated as hedging instruments: | Interest Expense
Derivative [Line Items]
Reclassification from AOCI				$ 2,100,000